J-VAC® 

Coliform Mastitis Vaccine 

Details

J-VAC® vaccine is a broad-spectrum bacterin-toxoid that protects against coliform mastitis caused by Escherichia coli and the effects of endotoxemia caused by E. coli and Salmonella Typhimurium.


It is approved for a whole-herd protocol and can be used for lactating cows, heifers or dry cows. 

Features & Benefits

Whole-Herd Protection

  • J-VAC® vaccine is the only vaccine of its kind approved for usage in the whole herd. 

  • In just two doses, J-VAC vaccine protects against coliform mastitis caused by E. coli and endotoxemia caused by E. coli and Salmonella Typhimurium. 

  • The unique TANDEM™ adjuvant in J-VAC vaccine keeps antigens in suspension, releases them over time, and stimulates enhanced immunity. 

Flexible Administration

  • J-VAC vaccine is easy to administer with a whole herd, two-dose protocol, and can reduce the incidence of clinical coliform mastitis cases by 81%.* 

  • Labeled for flexible administration, with intramuscular and subcutaneous injection-route options. 
     

*Data on file at Boehringer Ingelheim

Dosage & Administration

Administration 

  • For vaccination against coliform mastitis, inject one 2 mL dose intramuscularly or subcutaneously at seven months of gestation or at dry-off. Revaccinate one to three weeks before calving. Approved for whole-herd use. 

 

Timing 

  • For vaccination against the effects of endotoxemia, whole-herd vaccination may be done at any time. Vaccinate with one 2 mL dose followed by a second 2 mL dose two to four weeks later.

Resources
Safety

Always read and follow label directions.

white background
J-VAC 2 Dose Protocol

Proven Efficacy. Two Doses.

In a field trial with more than 700 cows and heifers, two doses of J-VAC vaccine reduced the incidence of clinical coliform mastitis cases by 81 percent.*

Proven Efficacy. Two Doses.

In a field trial with more than 700 cows and heifers, two doses of J-VAC vaccine reduced the incidence of clinical coliform mastitis cases by 81 percent.*

J-VAC 2 Dose Protocol

How to Administer J-VAC Vaccine

Managing E. Coli Mastitis

Dr. Mark van der List describes how to reduce the number mastitis cases caused by E. coli on the dairy.

Trademarks

J-VAC® and the J-VAC logo® are registered trademarks of Boehringer Ingelheim Animal Health USA Inc. All other trademarks are property of their respective owner. ©2023 Boehringer Ingelheim Animal Health USA Inc., Duluth, GA. All Rights Reserved. US-BOV-0394-2021-V2

US-BOV-0394-2021-V2